Canaccord Genuity raises Meta target price to $850 from $825
ByAinvest
Wednesday, Jul 16, 2025 12:16 am ET1min read
Canaccord Genuity raises Meta target price to $850 from $825
Title: Canaccord Genuity Raises Meta Target Price to $850Canaccord Genuity has raised its target price for Meta Platforms (NASDAQ:META) to $850 from $825, according to recent updates from the financial research firm. This adjustment comes amidst a backdrop of strong financial performance and strategic initiatives by Meta.
The firm's analysts cited robust revenue growth and the company's expanding user base as key drivers for the upward revision. Meta has been actively investing in its metaverse and augmented reality (AR) technologies, which are expected to drive future growth and revenue streams.
In the first quarter of 2025, Meta reported impressive financial results, with revenue reaching $22.4 billion, an increase of 18% year-over-year. The company's earnings per share (EPS) also exceeded expectations, reaching $2.10 compared to the projected $1.90. These strong results have bolstered analysts' confidence in Meta's ability to maintain its growth trajectory.
Additionally, Canaccord Genuity highlighted the potential of Meta's advertising business, which continues to dominate the digital advertising landscape. The company's strong brand recognition and extensive user base provide a solid foundation for sustained revenue growth.
The firm's revised target price reflects its optimism about Meta's long-term growth prospects and the company's strategic initiatives. As Meta continues to innovate and expand its offerings, investors can expect to see further positive developments that could drive the stock price higher.
For more information, see [1] https://www.investing.com/news/analyst-ratings/canaccord-genuity-raises-transmedics-stock-price-target-to-142-on-revenue-growth-93CH-4135379 and [2] https://www.marketbeat.com/ratings/by-issuer/canaccord-genuity-group-stock-recommendations/.
References:
[1] https://www.investing.com/news/analyst-ratings/canaccord-genuity-raises-transmedics-stock-price-target-to-142-on-revenue-growth-93CH-4135379
[2] https://www.marketbeat.com/ratings/by-issuer/canaccord-genuity-group-stock-recommendations/

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet